522 reports of this reaction
3.1% of all DOFETILIDE reports
#5 most reported adverse reaction
FATIGUE is the #5 most commonly reported adverse reaction for DOFETILIDE, manufactured by Pfizer Laboratories Div Pfizer Inc. There are 522 FDA adverse event reports linking DOFETILIDE to FATIGUE. This represents approximately 3.1% of all 17,040 adverse event reports for this drug.
Patients taking DOFETILIDE who experience fatigue should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
FATIGUE is moderately reported among DOFETILIDE users, representing a notable but not dominant share of adverse events.
In addition to fatigue, the following adverse reactions have been reported for DOFETILIDE:
The following drugs have also been linked to fatigue in FDA adverse event reports:
FATIGUE has been reported as an adverse event in 522 FDA reports for DOFETILIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
FATIGUE accounts for approximately 3.1% of all adverse event reports for DOFETILIDE, making it a notable side effect.
If you experience fatigue while taking DOFETILIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.